SYH2043 / CSPC Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SYH2043 / CSPC Pharma
NCT05728541: Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors

Not yet recruiting
1
367
RoW
SYH2043
CSPC Ouyi Pharmaceutical Co., Ltd.
Advanced Malignant Tumors
02/26
03/26

Download Options